Customise results display
Results 1-6 of 6 (Search time: 0.177 seconds).
|2004-11-01||Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus||Wang, XY; Martiniello-Wilks, R; Shaw, JM; Ho, T; Coulston, N; Cooke-Yarborough, C; Molloy, PL; Cameron, F; Moghaddam, M; Lockett, TJ; Webster, LK; Smith, IK; Both, GW; Russel, PJ|
|2004-01-01||Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease||Martiniello-Wilks, R; Dane, A; Voeks, DJ; Jeyakumar, G; Mortensen, E; Shaw, JM; Wang, XY; Both, GW; Russell, PJ|
|1998-03-01||Prostate cancer gene therapy||Russell, PJ; Martiniello-Wilks, R; Lockett, LJ; Brookes, DE; Zandvliet, D; Watt, F; Molloy, PL; Khatri, A; Both, GW|
|1998-07-20||In vivo gene therapy for prostate cancer: Preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors||Martiniello-Wilks, R; Garcia-Aragon, J; Daja, MM; Russell, P; Both, GW; Molloy, PL; Lockett, LJ; Russell, PJ|
|2004-12-01||Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer||Martiniello-Wilks, R; Wang, XY; Voeks, DJ; Dane, A; Shaw, JM; Mortensen, E; Both, GW; Russell, PJ|
|2002-01-01||Transcription-targeted gene therapy for androgen-independent prostate cancer||Martiniello-Wilks, R; Tsatralis, T; Russell, P; Brookes, DE; Zandvliet, D; Lockett, LJ; Both, GW; Molloy, PL; Russell, PJ|